GLP-1 drugs for diabetes and weight loss may influence patients’ cancer risk, usually lowering it but sometimes possibly ...

Ratings from both internal office staff and ICS umbrella employees saw the Lancaster firm come in the top 25, ahead of ...

Dynavax Technologies has revealed promising topline outcomes from the initial part of its Phase I/II clinical trial, ...

Bristol Myers leans on new launches to offset legacy drug declines, while GSK's diverse portfolio and strong HIV lineup keep growth on track.

Wes Streeting has walked away from talks with pharmaceutical giants on NHS drug costs amid a stand-off over rebates. The ...

The Emeryville, California-based biotech has just released topline results from a phase 1/2 head-to-head study comparing its ...

The Nigerian government has reduced the cost of dialysis for kidney patients from N50,000 to N12,000 per session at federal ...

Recently, a sharp increase in hepatitis A infections has been recorded in several European vacation destinations. The viruses can be transmitted in various ways. Before heading on vacation, it’s ...

Despite increased public awareness and improved treatment for irritable bowel syndrome, symptoms of IBS continue to disrupt ...

The Global Diabetic Neuropathy Market is expected to reach at a CAGR of 6.7% during the forecast period (2024-2031). The ...

Although infection prevention is an essential part of every rheumatologist’s routine, balancing efficacy, risk and individual patient choices — all while contending with a seemingly constant flow of ...

The Business Research Company The Business Research Company's Pediatric Asthma Treatment Global Market Report 2025 – Market Size, Trends, A ...